Government uncertainty drives jump in ACA silver plan insurance premiumsOctober 31, 2017Business of Medicine
“Great debates” at ACR 2017 address biosimilar switching, new curricular milestonesOctober 27, 2017Rheumatoid ArthritisBusiness of Medicine
Biosimilars poised to save $54 billion over the next decadeOctober 25, 2017Psoriatic ArthritisAnkylosing spondylitisRheumatoid ArthritisSpondyloarthropathiesBusiness of Medicine
Federal judge skeptical of claims that dropping subsidies hurts consumersOctober 24, 2017Business of Medicine
ACR: Use comparative effectiveness research for clinical decisions, not payers’ cost decisionsOctober 20, 2017Business of Medicine
